Indiana has a had a syringe exchange law on the books since 2015. Indiana Code 16-41-7.5 allows for the creation of syringe programs in the state. With the creation of these syringe programs, there ...

Pinar Uysal-Onganer receives funding from Prostate Cancer UK. Alwyn Dart does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this ...

Apple may have created a problem with the latest version of iOS. Since iOS 26 launched in September, there have been reports around the internet of the new update significantly shortening battery life ...

Kevin Collins receives research funding from Affinity Water and the Environment Agency. A woman was recently fined £150 by a council for pouring coffee down a drain before getting on a bus. The fine ...

Former President Joseph R. Biden Jr. began radiation therapy last month for an aggressive form of prostate cancer. It is unclear if his treatment has ended. By Yan Zhuang and Reid J. Epstein Former ...

Burcu Yesilyurt made the split-second choice to empty “just a tiny little bit” of coffee from a reusable cup of joe down the drain instead of risking spilling it on her bus to work in southwest London ...

Millions of US workers are unknowingly losing billions of dollars in retirement savings to so-called “Safe Harbor IRAs” — accounts meant to temporarily hold small 401(k) balances but which have ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Former UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of the disease, reviving a national debate on how to save more lives and ...

Leading scientists are advocating for annual prostate cancer screening for men with BRCA1 and BRCA2 gene mutations. Experts at the London-based Institute of Cancer Research (ICR) state that the ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. The trial results ...